BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32575753)

  • 21. Plk3 functions as an essential component of the hypoxia regulatory pathway by direct phosphorylation of HIF-1alpha.
    Xu D; Yao Y; Lu L; Costa M; Dai W
    J Biol Chem; 2010 Dec; 285(50):38944-50. PubMed ID: 20889502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inducible Protein Degradation as a Strategy to Identify Phosphoprotein Phosphatase 6 Substrates in RAS-Mutant Colorectal Cancer Cells.
    Mariano NC; Rusin SF; Nasa I; Kettenbach AN
    Mol Cell Proteomics; 2023 Aug; 22(8):100614. PubMed ID: 37392812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Function of polo-like kinase 3 in NF-kappaB-mediated proapoptotic response.
    Li Z; Niu J; Uwagawa T; Peng B; Chiao PJ
    J Biol Chem; 2005 Apr; 280(17):16843-50. PubMed ID: 15671037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polo-like kinase 3, hypoxic responses, and tumorigenesis.
    Xu D; Dai W; Li C
    Cell Cycle; 2017; 16(21):2032-2036. PubMed ID: 28857653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plk3 inhibits pro-apoptotic activity of p73 through physical interaction and phosphorylation.
    Sang M; Ando K; Okoshi R; Koida N; Li Y; Zhu Y; Shimozato O; Geng C; Shan B; Nakagawara A; Ozaki T
    Genes Cells; 2009 Jul; 14(7):775-88. PubMed ID: 19490146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of Plk3 in oncogenesis.
    Helmke C; Becker S; Strebhardt K
    Oncogene; 2016 Jan; 35(2):135-47. PubMed ID: 25915845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cdc25C phosphorylation on serine 191 by Plk3 promotes its nuclear translocation.
    Bahassi el M; Hennigan RF; Myer DL; Stambrook PJ
    Oncogene; 2004 Apr; 23(15):2658-63. PubMed ID: 14968113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polo-like kinase 1 inhibits DNA damage response during mitosis.
    Benada J; Burdová K; Lidak T; von Morgen P; Macurek L
    Cell Cycle; 2015; 14(2):219-31. PubMed ID: 25607646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian polo-like kinase, Plk3.
    Conn CW; Hennigan RF; Dai W; Sanchez Y; Stambrook PJ
    Cancer Res; 2000 Dec; 60(24):6826-31. PubMed ID: 11156373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polo-like kinase 3 is required for entry into S phase.
    Zimmerman WC; Erikson RL
    Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1847-52. PubMed ID: 17264206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation on PLK2 and PLK3 substrate recognition.
    Salvi M; Trashi E; Cozza G; Franchin C; Arrigoni G; Pinna LA
    Biochim Biophys Acta; 2012 Dec; 1824(12):1366-73. PubMed ID: 22828320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutual regulation between Polo-like kinase 3 and SIAH2 E3 ubiquitin ligase defines a regulatory network that fine-tunes the cellular response to hypoxia and nickel.
    Li C; Park S; Zhang X; Dai W; Xu D
    J Biol Chem; 2017 Jul; 292(27):11431-11444. PubMed ID: 28515325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical and functional interactions between mitotic kinases during polyploidization and megakaryocytic differentiation.
    Huang X; Ruan Q; Fang Y; Traganos F; Darzynkiewicz Z; Dai W
    Cell Cycle; 2004 Jul; 3(7):946-51. PubMed ID: 15190214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein phosphatases regulate DNA-dependent protein kinase activity.
    Douglas P; Moorhead GB; Ye R; Lees-Miller SP
    J Biol Chem; 2001 Jun; 276(22):18992-8. PubMed ID: 11376007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium-dependent inhibition of polo-like kinase 3 activity by CIB1 in breast cancer cells.
    Naik MU; Pham NT; Beebe K; Dai W; Naik UP
    Int J Cancer; 2011 Feb; 128(3):587-96. PubMed ID: 20473878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.
    Tsvetkov L; Stern DF
    Cell Cycle; 2005 Jan; 4(1):166-71. PubMed ID: 15611664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Functional Significance of Posttranslational Modifications on Polo-Like Kinase 1 Revealed by Chemical Genetic Complementation.
    Lasek AL; McPherson BM; Trueman NG; Burkard ME
    PLoS One; 2016; 11(2):e0150225. PubMed ID: 26919439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphatase ABI1 and okadaic acid-sensitive phosphoprotein phosphatases inhibit salt stress-activated SnRK2.4 kinase.
    Krzywińska E; Bucholc M; Kulik A; Ciesielski A; Lichocka M; Dębski J; Ludwików A; Dadlez M; Rodriguez PL; Dobrowolska G
    BMC Plant Biol; 2016 Jun; 16(1):136. PubMed ID: 27297076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polo-like kinase 3 is Golgi localized and involved in regulating Golgi fragmentation during the cell cycle.
    Ruan Q; Wang Q; Xie S; Fang Y; Darzynkiewicz Z; Guan K; Jhanwar-Uniyal M; Dai W
    Exp Cell Res; 2004 Mar; 294(1):51-9. PubMed ID: 14980500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WIP1, a homeostatic regulator of the DNA damage response, is targeted by HIPK2 for phosphorylation and degradation.
    Choi DW; Na W; Kabir MH; Yi E; Kwon S; Yeom J; Ahn JW; Choi HH; Lee Y; Seo KW; Shin MK; Park SH; Yoo HY; Isono K; Koseki H; Kim ST; Lee C; Kwon YK; Choi CY
    Mol Cell; 2013 Aug; 51(3):374-85. PubMed ID: 23871434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.